The official blog of the Lung Institute.

World COPD Day in Downtown Tampa

18 Nov 2014
| Under Press | Posted by | 0 Comments

TAMPA, FL- On Wednesday, November 19, The Lung Institute will host a free advocacy event on Franklin Street outside of Lykes Gaslight Square Park in downtown. Chronic obstructive pulmonary disease (COPD) is a common lung condition that obstructs the breathing of many individuals. The Lung Institute offers stem cell therapy to treat COPD, as well as several other lung diseases. This event will raise awareness for COPD; as people often have very little knowledge about it. This is the first year that the event is being held by the Lung Institute.

The Lung Institute will raise public awareness by offering informational flyers on COPD and engaging community members. There will also be prizes and giveaways at the event, which will serve as a reminder for World COPD Day.

World COPD Day is organized annually by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). They partner with healthcare professionals, educators and the general public who want to alleviate the hardships that those with COPD face. The first COPD day was held in 2002 and has been growing each year. Recently, there have been events organized in over 50 countries around the world.

People diagnosed with COPD face many obstacles daily. Some rely on oxygen to get through the day and find it difficult to complete even the most common tasks without struggling. The Lung Institute encourages citizens to take part in World COPD Day.

Join us for World COPD Day:

When: Wednesday, November 19, 2014 from 11 a.m. to 2 p.m.

Where: Franklin Street outside of Lykes Gaslight Square Park in Tampa, FL.

About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life.  Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (800) 729-3065



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.